UniProt ID | ERO1A_HUMAN | |
---|---|---|
UniProt AC | Q96HE7 | |
Protein Name | ERO1-like protein alpha | |
Gene Name | ERO1A {ECO:0000312|HGNC:HGNC:13280} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 468 | |
Subcellular Localization |
Endoplasmic reticulum membrane Peripheral membrane protein Lumenal side . The association with ERP44 is essential for its retention in the endoplasmic reticulum. |
|
Protein Description | Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to sustain additional rounds of disulfide formation. Following P4HB reoxidation, passes its electrons to molecular oxygen via FAD, leading to the production of reactive oxygen species (ROS) in the cell. Required for the proper folding of immunoglobulins. Involved in the release of the unfolded cholera toxin from reduced P4HB/PDI in case of infection by V.cholerae, thereby playing a role in retrotranslocation of the toxin. Plays an important role in ER stress-induced, CHOP-dependent apoptosis by activating the inositol 1,4,5-trisphosphate receptor IP3R1.. | |
Protein Sequence | MGRGWGFLFGLLGAVWLLSSGHGEEQPPETAAQRCFCQVSGYLDDCTCDVETIDRFNNYRLFPRLQKLLESDYFRYYKVNLKRPCPFWNDISQCGRRDCAVKPCQSDEVPDGIKSASYKYSEEANNLIEECEQAERLGAVDESLSEETQKAVLQWTKHDDSSDNFCEADDIQSPEAEYVDLLLNPERYTGYKGPDAWKIWNVIYEENCFKPQTIKRPLNPLASGQGTSEENTFYSWLEGLCVEKRAFYRLISGLHASINVHLSARYLLQETWLEKKWGHNITEFQQRFDGILTEGEGPRRLKNLYFLYLIELRALSKVLPFFERPDFQLFTGNKIQDEENKMLLLEILHEIKSFPLHFDENSFFAGDKKEAHKLKEDFRLHFRNISRIMDCVGCFKCRLWGKLQTQGLGTALKILFSEKLIANMPESGPSYEFHLTRQEIVSLFNAFGRISTSVKELENFRNLLQNIH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
40 | Phosphorylation | QRCFCQVSGYLDDCT HHHHHHHHCCCCCCC | 8.88 | 30576142 | |
47 | Phosphorylation | SGYLDDCTCDVETID HCCCCCCCCCCHHHH | 20.80 | 30576142 | |
52 | Phosphorylation | DCTCDVETIDRFNNY CCCCCCHHHHCCCCC | 28.20 | 30576142 | |
59 | Phosphorylation | TIDRFNNYRLFPRLQ HHHCCCCCCHHHHHH | 15.14 | - | |
67 | 2-Hydroxyisobutyrylation | RLFPRLQKLLESDYF CHHHHHHHHHHCCCH | 60.68 | - | |
67 | Ubiquitination | RLFPRLQKLLESDYF CHHHHHHHHHHCCCH | 60.68 | 23000965 | |
71 | Phosphorylation | RLQKLLESDYFRYYK HHHHHHHCCCHHEEE | 37.26 | 29449344 | |
73 | Phosphorylation | QKLLESDYFRYYKVN HHHHHCCCHHEEECC | 10.15 | 19658100 | |
75 | Methylation | LLESDYFRYYKVNLK HHHCCCHHEEECCCC | 27.87 | - | |
102 | Acetylation | GRRDCAVKPCQSDEV CCCCCCCCCCCCCCC | 22.88 | 26822725 | |
106 | Phosphorylation | CAVKPCQSDEVPDGI CCCCCCCCCCCCCCH | 42.32 | 26657352 | |
115 | Phosphorylation | EVPDGIKSASYKYSE CCCCCHHHCHHHCCH | 22.11 | 25022875 | |
120 | Phosphorylation | IKSASYKYSEEANNL HHHCHHHCCHHHHHH | 17.06 | 27486199 | |
121 | Phosphorylation | KSASYKYSEEANNLI HHCHHHCCHHHHHHH | 25.47 | 27486199 | |
131 | Glutathionylation | ANNLIEECEQAERLG HHHHHHHHHHHHHHC | 2.81 | 22555962 | |
143 | Phosphorylation | RLGAVDESLSEETQK HHCCCCHHCCHHHHH | 32.50 | 28355574 | |
145 | Phosphorylation | GAVDESLSEETQKAV CCCCHHCCHHHHHHH | 42.54 | 25262027 | |
150 | Ubiquitination | SLSEETQKAVLQWTK HCCHHHHHHHHHHHC | 48.13 | 21906983 | |
166 | Glutathionylation | DDSSDNFCEADDIQS CCCCCCCCCCCCCCC | 5.45 | 22555962 | |
192 | Ubiquitination | PERYTGYKGPDAWKI HHHHCCCCCCCHHHH | 66.37 | 29967540 | |
208 | Glutathionylation | NVIYEENCFKPQTIK HHHHCCCCCCCCCCC | 5.40 | 22555962 | |
210 | Acetylation | IYEENCFKPQTIKRP HHCCCCCCCCCCCCC | 38.11 | 26051181 | |
248 | Phosphorylation | CVEKRAFYRLISGLH HHHHHHHHHHHHHHH | 11.97 | - | |
266 | Phosphorylation | NVHLSARYLLQETWL HHHHHHHHHHHHHHH | 16.10 | - | |
275 | Acetylation | LQETWLEKKWGHNIT HHHHHHHHHHCCCHH | 52.21 | 27452117 | |
280 | N-linked_Glycosylation | LEKKWGHNITEFQQR HHHHHCCCHHHHHHH | 38.65 | 19159218 | |
293 | Phosphorylation | QRFDGILTEGEGPRR HHHCCCCCCCCCHHH | 39.77 | - | |
353 | Phosphorylation | EILHEIKSFPLHFDE HHHHHHHHCCCCCCC | 37.44 | - | |
368 | 2-Hydroxyisobutyrylation | NSFFAGDKKEAHKLK CCCCCCCHHHHHHHH | 52.15 | - | |
384 | N-linked_Glycosylation | DFRLHFRNISRIMDC HHHHHHCCHHHHHHH | 35.33 | UniProtKB CARBOHYD | |
392 | Ubiquitination | ISRIMDCVGCFKCRL HHHHHHHHHHHHHHH | 6.97 | 24816145 | |
396 | Ubiquitination | MDCVGCFKCRLWGKL HHHHHHHHHHHHHHH | 23.63 | 24816145 | |
396 | 2-Hydroxyisobutyrylation | MDCVGCFKCRLWGKL HHHHHHHHHHHHHHH | 23.63 | - | |
405 | Phosphorylation | RLWGKLQTQGLGTAL HHHHHHHHCCHHHHH | 34.73 | - | |
424 | Sulfoxidation | SEKLIANMPESGPSY CHHHHHCCCCCCCCE | 2.62 | 30846556 | |
431 | Phosphorylation | MPESGPSYEFHLTRQ CCCCCCCEEEEECHH | 26.25 | - | |
451 | Ubiquitination | FNAFGRISTSVKELE HHHHHCCCCCHHHHH | 17.17 | 24816145 | |
455 | Ubiquitination | GRISTSVKELENFRN HCCCCCHHHHHHHHH | 57.24 | 24816145 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERO1A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERO1A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ERP44_HUMAN | ERP44 | physical | 11847130 | |
PDIA1_HUMAN | P4HB | physical | 11847130 | |
PDIA1_HUMAN | P4HB | physical | 11707400 | |
PDIA2_HUMAN | PDIA2 | physical | 20802462 | |
PDIA3_HUMAN | PDIA3 | physical | 20802462 | |
PDIA4_HUMAN | PDIA4 | physical | 20802462 | |
PELI2_HUMAN | PELI2 | physical | 21988832 | |
DDX5_HUMAN | DDX5 | physical | 22863883 | |
HPBP1_HUMAN | HSPBP1 | physical | 22863883 | |
LRSM1_HUMAN | LRSAM1 | physical | 22863883 | |
PPME1_HUMAN | PPME1 | physical | 22863883 | |
RINI_HUMAN | RNH1 | physical | 22863883 | |
WDR4_HUMAN | WDR4 | physical | 22863883 | |
GPX7_HUMAN | GPX7 | physical | 21215271 | |
GPX8_HUMAN | GPX8 | physical | 21215271 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-280, AND MASSSPECTROMETRY. |